Trials / Completed
CompletedNCT03392662
Hemopatch Performance Evaluation: A Prospective Observational Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 621 (actual)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To assess the clinical performance and safety of HEMOPATCH Sealing Hemostat in a post-marketing setting in cardiovascular, thoracic, urologic, neurological, and other general surgical procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hemopatch | Patients received product at the discretion of their surgeon. |
Timeline
- Start date
- 2017-11-29
- Primary completion
- 2019-01-28
- Completion
- 2019-01-28
- First posted
- 2018-01-08
- Last updated
- 2022-11-16
Locations
15 sites across 5 countries: Austria, Czechia, Germany, Italy, Spain
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03392662. Inclusion in this directory is not an endorsement.